Opaleye Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-450,000
| Closed | -$8.18M | – | 36 |
|
|
2017
Q3 | $8.18M | Sell |
450,000
-10,000
| -2% | -$182K | 2.89% | 11 |
|
|
2017
Q2 | $7.13M | Buy |
460,000
+120,000
| +35% | +$1.86M | 2.98% | 10 |
|
|
2017
Q1 | $5.87M | Buy |
340,000
+170,000
| +100% | +$2.94M | 2.92% | 11 |
|
|
2016
Q4 | $1.87M | Buy |
170,000
+10,000
| +6% | +$110K | 1.1% | 27 |
|
|
2016
Q3 | $2.51M | Hold |
160,000
| – | – | 1.31% | 28 |
|
|
2016
Q2 | $1.63M | Buy |
+160,000
| New | +$1.63M | 1.09% | 35 |
|